Sean Salmon - Feb 21, 2024 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Feb 21, 2024
Transactions value $
-$492,934
Form type
4
Date filed
2/23/2024, 05:18 PM
Previous filing
Dec 12, 2023
Next filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $100K +1.59K +3.3% $62.76 49.8K Feb 21, 2024 Direct F1
transaction MDT Ordinary Shares Options Exercise $820K +13.1K +26.19% $62.76 62.9K Feb 21, 2024 Direct
transaction MDT Ordinary Shares Options Exercise $1.2M +16K +25.47% $74.84 79K Feb 21, 2024 Direct
transaction MDT Ordinary Shares Sale -$136K -1.59K -2.02% $85.06 77.4K Feb 21, 2024 Direct
transaction MDT Ordinary Shares Sale -$1.11M -13.1K -16.88% $85.15 64.3K Feb 21, 2024 Direct F2
transaction MDT Ordinary Shares Sale -$1.36M -16K -24.93% $85.12 48.3K Feb 21, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1.59K -10.87% $0.00 13.1K Feb 21, 2024 Ordinary Shares 1.59K $62.76 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -13.1K -100% $0.00* 0 Feb 21, 2024 Ordinary Shares 13.1K $62.76 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -16K -100% $0.00* 0 Feb 21, 2024 Ordinary Shares 16K $74.84 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person.
F2 The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
F3 The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.